Wound Care: Advanced Dressings and Closure Products
Wound Care: Advanced Dressings and Closure Products
$4,750.00
In 2019, sales of advanced wound care products in the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and Rest of World markets totaled nearly $8.2bn;
Publisher: Meddevicetracker
- Highlights
- Description
- Contents
Highlights
- In 2019, global sales of the advanced wound care products covered by this report totaled nearly $8.2bn; of this, advanced wound closure products accounted for 58.5% of sales, with advanced wound dressings accounting for the remaining 41.5%.
- In 2019, the advanced wound dressings products covered by this report generated an estimated $3.4bn in worldwide sales, with foam dressings accounting for nearly half of sales. Although the growth rate over the next half-decade appears slow at 2.9%, this is due to declines in the market in 2020–21 resulting from a decrease in surgical procedure volumes because of the COVID-19 pandemic, followed by a return to more typical (high-single-digit) growth rates in subsequent years.
- In 2019, the advanced wound closure products covered by this report generated an estimated $4.8bn in global sales, with surgical sealants/glues accounting for just over half of sales. As in the dressings market, the combined growth rate appears low at 0.6%; however, this is due to declines in 2020–21 due to a reduced number of elective and deferrable procedures resulting from the COVID-19 pandemic, with a surge in 2022 as deferred procedures are rescheduled and a return to more traditional (mid-single-digit) growth rates for the remainder of the forecast.
Key topics covered
- This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global markets for advanced dressings (including alginate, film, foam, hydrocolloid, hydrogel, contact layer, and antimicrobial) and advanced closure products (including surgical sealants/glues, energy-based devices, automated suturing products, and negative pressure wound therapy products).
OVERVIEW
In 2019, sales of advanced wound care products in the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and Rest of World markets totaled nearly $8.2bn; of this, advanced wound closure products (surgical sealants/glues, energy-based wound closure devices, automated suturing products, and negative pressure wound therapy products) accounted for 58.5% of sales, with advanced wound dressings (alginate, film, foam, hydrocolloid, hydrogel, contact layer, and antimicrobial dressings) accounting for the remaining 41.5%. This report provides a discussion of these wound care technologies and products, as well as current and forecast market analyses (including a discussion of the market impact of the COVID-19 pandemic), a competitive analysis, and market drivers/limiters for the 2019–24 forecast range.
CONTENTS
Executive Summary …………………………………………………………………….. ES-1
i. Advanced wound dressings ……………………………………………………………………………… ES-1
ii. Advanced wound closure products …………………………………………………………………… ES-5
iii. Market analysis ……………………………………………………………………………………………. ES-8
iv. Methodology ……………………………………………………………………………………………… ES-11
Exhibit ES-1: Advanced wound dressings and closure products, market forecast ($m), by segment, 2019–24 ………………………………………………………………………………….. ES-9
Exhibit ES-2: Advanced wound dressings and closure products, market forecast ($m), by region, 2019–24 ……………………………………………………………………………….. ES-10
1. Advanced Wound Dressings ……………………………………………………….. 1-1
1.1 Alginate dressings …………………………………………………………………………………………. 1-1
1.1.1 Market forecast ………………………………………………………………………………. 1-4
1.1.2 Competitive analysis ………………………………………………………………………… 1-5
1.2 Film dressings ……………………………………………………………………………………………… 1-12
1.2.1 Market forecast …………………………………………………………………………….. 1-14
1.2.2 Competitive analysis ………………………………………………………………………. 1-16
1.3 Foam dressings……………………………………………………………………………………………. 1-20
1.3.1 Market forecast …………………………………………………………………………….. 1-22
1.3.2 Competitive analysis ………………………………………………………………………. 1-24
1.4 Hydrocolloid dressings …………………………………………………………………………………. 1-26
1.4.1 Market forecast …………………………………………………………………………….. 1-28
1.4.2 Competitive analysis ………………………………………………………………………. 1-29
1.5 Hydrogel wound care products ………………………………………………………………………. 1-32
1.5.1 Market forecast …………………………………………………………………………….. 1-34
1.5.2 Competitive analysis ………………………………………………………………………. 1-36
1.6 Wound contact layer dressings ………………………………………………………………………. 1-38
1.6.1 Market forecast …………………………………………………………………………….. 1-40
1.6.2 Competitive analysis ………………………………………………………………………. 1-42
1.7 Antimicrobial dressings ………………………………………………………………………………… 1-44
1.7.1 Market forecast …………………………………………………………………………….. 1-46
1.7.2 Competitive analysis ………………………………………………………………………. 1-48
1.8 Emerging technologies …………………………………………………………………………………. 1-50
1.9 Combined market analysis …………………………………………………………………………….. 1-51
1.10 Bibliography ……………………………………………………………………………………………… 1-53
Exhibit 1-1: Selected alginate wound dressings, 2020 ……………………………………………….. 1-3
Exhibit 1-2: Alginate wound dressings, market forecast ($m), 2019–24 ……………………….. 1-5
Exhibit 1-3: ConvaTec, revenues by segment, FY2019 ……………………………………………….. 1-6
Exhibit 1-4: Cardinal Health, revenues by segment, FY2020 ……………………………………….. 1-8
Exhibit 1-5: Mölnlycke Health Care, revenues by segment, FY2019 ……………………………… 1-9
Exhibit 1-6: 3M, revenues by segment, FY2019 ……………………………………………………… 1-10
Exhibit 1-7: Alginate wound dressings market, share by supplier ($m), 2019 ………………. 1-11
Exhibit 1-8: Selected film wound dressings, 2020 …………………………………………………… 1-13
Exhibit 1-9: Film wound dressings, market forecast ($m), 2019–24 …………………………… 1-15
Exhibit 1-10: Smith & Nephew, revenues by segment, FY2019 …………………………………. 1-17
Exhibit 1-11: Acelity, revenues by segment, FY2018 ……………………………………………….. 1-19
Exhibit 1-12: Film wound dressings market, share by supplier ($m), 2019 ………………….. 1-20
Exhibit 1-13: Selected foam wound dressings, 2020 ……………………………………………….. 1-21
Exhibit 1-14: Foam wound dressings, market forecast ($m), 2019–24 ……………………….. 1-23
Exhibit 1-15: Foam wound dressings market, share by supplier ($m), 2019 ………………… 1-26
Exhibit 1-16: Selected hydrocolloid wound dressings, 2020 ……………………………………… 1-27
Exhibit 1-17: Hydrocolloid wound dressings, market forecast ($m), 2019–24 ……………… 1-29
Exhibit 1-18: Hydrocolloid wound dressings market, share by supplier ($m), 2019 ………. 1-31
Exhibit 1-19: Selected hydrogel wound dressings, 2020 …………………………………………… 1-33
Exhibit 1-20: Hydrogel wound care products, market forecast ($m), 2019–24 …………….. 1-35
Exhibit 1-21: Hydrogel wound care products market, share by supplier ($m), 2019 ……… 1-37
Exhibit 1-22: Selected wound contact layer dressings, 2020 …………………………………….. 1-39
Exhibit 1-23: Wound contact layer dressings, market forecast ($m), 2019–24 …………….. 1-41
Exhibit 1-24: Wound contact layer dressings market, share by supplier ($m), 2019 ……… 1-43
Exhibit 1-25: Selected silver-containing antimicrobial wound dressings, 2020 …………….. 1-45
Exhibit 1-26: Silver-containing antimicrobial wound dressings, market forecast ($m), 2019–24 ………………………………………………………………… 1-47
Exhibit 1-27: Silver-containing antimicrobial wound dressings market, share by supplier ($m), 2019 ……………………………………………………………………. 1-49
Exhibit 1-28: Advanced wound dressings, combined market forecast ($m), 2019–24 …… 1-52
2. Advanced Wound Closure Products ……………………………………………… 2-1
2.1 Surgical sealants and glues ……………………………………………………………………………… 2-1
2.1.1 Applications ……………………………………………………………………………………. 2-2
2.1.2 Fibrin sealants …………………………………………………………………………………. 2-4
2.1.3 Autologous-processed sealants ………………………………………………………….. 2-5
2.1.4 Collagen- and albumin-based sealants ………………………………………………… 2-5
2.1.5 Cyanoacrylate-based sealants ……………………………………………………………. 2-6
2.1.6 Polymer-based sealants ……………………………………………………………………. 2-7
2.1.7 Market analysis ……………………………………………………………………………… 2-10
2.1.8 Competitive analysis ………………………………………………………………………. 2-12
2.2 Energy-based wound closure devices ……………………………………………………………… 2-17
2.2.1 Radiofrequency closure…………………………………………………………………… 2-17
2.2.2 Ultrasonic closure ………………………………………………………………………….. 2-18
2.2.3 Thermal closure …………………………………………………………………………….. 2-18
2.2.4 Market analysis ……………………………………………………………………………… 2-20
2.2.5 Competitive analysis ………………………………………………………………………. 2-22
2.3 Automated suturing devices ………………………………………………………………………….. 2-29
2.3.1 Market analysis ……………………………………………………………………………… 2-31
2.3.2 Competitive analysis ………………………………………………………………………. 2-34
2.4 Negative pressure wound therapy ………………………………………………………………….. 2-35
2.4.1 Market analysis ……………………………………………………………………………… 2-38
2.4.2 Competitive analysis ………………………………………………………………………. 2-41
2.5 Emerging technologies …………………………………………………………………………………. 2-43
2.6 Combined market analysis …………………………………………………………………………….. 2-44
2.7 Bibliography ……………………………………………………………………………………………….. 2-46
Exhibit 2-1: Selected surgical sealants and glues, 2020 ……………………………………………… 2-8
Exhibit 2-2: Surgical sealants and glues, market forecast ($m), 2019–24 …………………….. 2-11
Exhibit 2-3: Baxter, revenues by segment, FY2019 ………………………………………………….. 2-13
Exhibit 2-4: Johnson & Johnson, revenues by segment, FY2019 ………………………………… 2-14
Exhibit 2-5: CryoLife, revenues by segment, FY2019 ……………………………………………….. 2-15
Exhibit 2-6: Surgical sealants and glues market, share by supplier ($m), 2019 …………….. 2-16
Exhibit 2-7: Selected energy-based wound closure devices, 2020 ……………………………… 2-19
Exhibit 2-8: Energy-based wound closure devices, market forecast ($m), 2019–24 ………. 2-22
Exhibit 2-9: Olympus, revenues by segment, FY2020 ………………………………………………. 2-24
Exhibit 2-10: Medtronic, revenues by segment, FY2020 ………………………………………….. 2-26
Exhibit 2-11: Smith & Nephew, revenues by segment, FY2019 …………………………………. 2-27
Exhibit 2-12: Energy-based wound closure devices market, share by supplier ($m), 2019 ……………………………………………………………………. 2-28
Exhibit 2-13: Selected automated suturing devices, 2020 ………………………………………… 2-30
Exhibit 2-14: Automated suturing devices, market forecast ($m), 2019–24 ………………… 2-33
Exhibit 2-15: Automated suturing devices market, share by supplier ($m), 2019 …………. 2-35
Exhibit 2-16: Selected negative pressure wound therapy systems, 2020 …………………….. 2-37
Exhibit 2-17: Negative pressure wound therapy products, market forecast ($m), 2019–24 ……………………………………………………………………………………………….. 2-40
Exhibit 2-18: Acelity, revenues by segment, FY2018 ……………………………………………….. 2-42
Exhibit 2-19: Negative pressure wound therapy products market, share by supplier ($m), 2019 ……………………………………………………………………. 2-43
Exhibit 2-20: Advanced wound closure products, combined market forecast ($m), 2019–24 ……………………………………………………………………………………………….. 2-45
Appendix: Company Listing ……………………………………………………………. A-1
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Prostate Cancer KOL Interview – US 
Sign up to the